July 17th 2024
Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.
Q&A: How to Manage Burnout in the Pharmacy
June 10th 2024“The more we share our experiences and stories and work together as a profession, the more we can come together to support each other and form solutions,” said Joanna Lewis, PharmD, MBA, wellness writer and advocate, on overcoming burnout in the pharmacy.
The Psychedelic Pharmacy: A Paradigm Shift in Mental Health Treatment
April 12th 2024After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?
Psychedelic Therapeutics: Education, Advocacy Key to Overcoming Integration Hurdles
March 26th 2024According to Sa’ed Al-Olimat, education and advocacy are key to ensure a safe and accessible landscape of psychedelic therapeutics, especially as the compounds inch closer to the mainstream health care market.
Navigating Pediatric ADHD Medication Shortages
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.